or Try an Advanced Search...

    Respiratory Infection Stocks List

    Symbol Grade Name % Change
    AZN A Astrazeneca PLC 1.47
    PRPH F ProPhase Labs, Inc. 0.00
    TDOC F Teladoc, Inc. -1.99
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Health Information Services
    Related Stock Lists: Upper Respiratory Infection Acid Allergy Anemia Angina Antibodies Assistive Technology Asthma Autoimmune And Inflammatory Disease Bipolar Disorder Breast Cancer Cancer Cholesterol Chronic Condition Chronic Kidney Disease Chronic Obstructive Pulmonary Disease Contract Manufacturing Contract Manufacturing Services Coronavirus Cough

    Related ETFs - A few ETFs which own one or more of the above listed Respiratory Infection stocks.

    Symbol Grade Name Weight
    PPH B Market Vectors Pharmaceutical ETF 5.86
    MEDX D Horizon Kinetics Medical ETF 5.71
    IBBQ B Invesco Nasdaq Biotechnology ETF 4.62
    FLUD A Franklin Liberty Ultra Short Bond ETF 4.07
    AGNG C Global X Aging Population ETF 3.2
    View all Respiratory Infection ETFs...
    Compare ETFs
    Compare IBBQ to AGNG Compare IBBQ to FLUD Compare MEDX to FLUD

        Respiratory Infection Stocks Recent News

        Date Stock Title
        May 21 AZN AstraZeneca projects $80B in revenue by 2030
        May 21 AZN AstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline Expansion
        May 21 AZN Trending tickers: Trump Media, Palo Alto, AstraZeneca and Kingfisher
        May 21 AZN AstraZeneca to establish $1.5bn ADC production site in Singapore
        May 21 AZN Lowe's, Macy's, Xpeng rise premarket; Palo Alto, Zoom fall
        May 21 AZN AstraZeneca Targets $80 Billion Revenue by 2030 Through Pipeline Expansion
        May 21 AZN AstraZeneca shares rise as pharma group unveils 2030 revenue target
        May 21 AZN AstraZeneca aims for $80 billion in total revenue by 2030
        May 21 AZN AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
        May 21 AZN European stocks fall on Fed rate concerns; AstraZeneca lifts revenue target
        May 20 AZN Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
        May 20 AZN Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population
        May 20 AZN AstraZeneca, Amgen release mid-stage data on Tezspire for COPD
        May 20 AZN AstraZeneca to build $1.5B ADC manufacturing plant in Singapore
        May 20 AZN AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
        May 20 AZN Trending tickers: Gold, Ryanair, Nvidia and AstraZeneca
        May 20 AZN AstraZeneca to build $1.5bn ADCs facility in Singapore
        May 20 AZN Pfizer wins cancer drug patent case against AstraZeneca
        May 20 AZN AstraZeneca Plans $1.5 Billion Manufacturing Facility In Singapore
        May 19 AZN New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease
        Related Industries: Drug Manufacturers - Major Health Information Services
        Related Stock Lists: Upper Respiratory Infection Acid Allergy Anemia Angina Antibodies Assistive Technology Asthma Autoimmune And Inflammatory Disease Bipolar Disorder Breast Cancer Cancer Cholesterol Chronic Condition Chronic Kidney Disease Chronic Obstructive Pulmonary Disease Contract Manufacturing Contract Manufacturing Services Coronavirus Cough
        Respiratory Infection

        Respiratory infections are infections that affect the lungs, airways, and other parts of the respiratory system. They can be caused by viruses, bacteria, fungi, or parasites. Common symptoms of respiratory infections include coughing, sneezing, sore throat, fever, and difficulty breathing. Treatment depends on the type of infection and may include antibiotics, antivirals, or other medications.

        Browse All Tags